To examine whether PD-1–laIL-2 can effectively recover the functionality of dysfunctional T cells, we examined the cytotoxic function of PD-1+TIM3+ CD8+ T cells from the tumor-bearing mice after PD-1–laIL-2 treatment. The gene discussed is HAVCR2; the disease is neoplasm.